We have recently identified in two unrelated patients with bleeding tendency a homozygous mutation causing a deletion of one of the two contiguous Lys 9 /Lys 10 residues in the A-chain of ␣-thrombin (⌬K9). We used in vitro expression analysis to clarify the role of the deletion of Lys 9 or Lys 10 in the thrombin function. The k cat /K m value of the hydrolysis by ⌬K9 of the synthetic substrate PhePip-Arg-p-nitroanilide (where Pip represents L-pipecolyl) and fibrinopeptide A was 18-and 60-fold lower, respectively, compared with wild type (WT). Interaction with antithrombin was also reduced in the mutant, the association rate being about 20-fold lower than in the WT thrombin. The sensitivity to sodium ion of ⌬K9 was found significantly attenuated compared with the WT form. ⌬K9 has a very weak platelet-activating capacity, attributed to a severely defective PAR1 interaction, whereas the binding to the platelet glycoprotein Ib␣ was unaffected. Likewise, the interaction with protein C was severely impaired, whereas interaction with thrombomodulin had a normal K d value. At variance with these findings, both low affinity (basic pancreatic trypsin inhibitor) and high affinity (N-␣-[2-naphthylsulfonyl-glycyl]-4-amidinophenylalanine-piperidide) thrombin inhibitors displayed a better binding to ⌬K9 than to the WT form, indicating a better accommodation of these inhibitors into the catalytic pocket of ⌬K9. A molecular dynamics simulation of the ⌬K9 thrombin in full explicit water solvent provided support to the role of the Achain in affecting conformation and catalytic properties of the B-chain, especially in some insertion loops of the enzyme, such as the 60-loop, as well as in the geometry of the catalytic triad residues.
Recently, a homozygous deletion mutation of one of the two contiguous Lys 9 /Lys 10 residues 1 in the A-chain of ␣-thrombin was identified in two unrelated Iranian patients with severe prothrombin deficiency and hemorrhagic diathesis (1) . The level of prothrombin antigen measured in plasma was 15%, whereas the coagulant activity ranged from less than 1% to about 2.5% (1) . Prothrombin deficiency is an autosomal recessive bleeding disorder characterized by two phenotypes: hypoprothrombinemia, with concomitantly low levels of coagulant activity and antigen (type I), and dysprothrombinemia, with very low activity but subnormal or normal antigen levels (type II). These disorders are rare, and there is always residual prothrombin procoagulant activity measurable in patients, the phenotype found in prothrombin-deficient mice indicating that complete prothrombin deficiency may be lethal in humans (2, 3) . To date, 38 defects in the prothrombin gene have been identified in patients with dysprothrombinemia or hypoprothrombinemia (1, 4 -7) . Among these natural dysprothrombins, amino acid residues of the thrombin A-chain were found to be rarely involved (1, 4 -7) .
The A-chain in human thrombin is composed of 36 amino acid residues, which are connected to the catalytic B-chain by a single disulfide bond (8) . This chain has no analog in the prototypic serine protease trypsin, although chymotrypsin and other trypsin-like blood coagulation enzymes, such as factor IX and factor XI, contain A-chain analogs (9, 10) . Some structural analogies between the A-chains present in different serine proteases, as in the case of thrombin and chymotrypsin, were identified, although the function of the A-chain has not yet been well established.
The thrombin A-chain is organized mainly in a multiple-turn and partly helical conformation and a boomerang-like shape, making a smooth contour of the B-chain part, opposite to the active site pocket (8) . The A-chain is topologically similar to the activation peptide of chymotrypsin(ogen) and connected in a similar manner through the Cys 1 -Cys 122 disulfide bridge to the B-chain. Most of the A-B chain interactions involve charged side chains; six are buried salt bridges, and 10 are involved in interchain hydrogen bonds (8) . Stabilization within the A-chain also occurs, mostly via polar and salt bridge interactions. The N-terminal segment of the A-chain up to E1c is characterized by relatively weak electron density in the D-Phe-Pro-Argmethyl ketone-thrombin crystal (8) , and seems to have a high degree of conformational flexibility (8) . The C-terminal segment up to Y14j is an amphiphilic ␣-helix forming one and one-half turns and showing a high degree of flexibility as well (8) . The central region is the most rigid segment of the A-chain and contains strong salt bridges, such as that involving the Asp 1a -Lys 9 side chains (8) , which is characterized by a high electrostatic energy (Ϫ1.8 kcal/mol), significantly contributing to confer the boomerang-like shape to the chain (8) .
Not all of the coagulation serine proteases bear an A-chain, hence its general role has not been precisely established. In a previous study, carried out on bovine thrombin, it has been proposed that the A-chain, although strongly linked to the B-chain through strong electrostatic and apolar bonds, does not play a major role in the specificity of the enzyme catalytic activity (11) . In contrast, subsequent studies carried out on human thrombin showed that isolated B-chain has a markedly reduced proteolytic and amidase activity compared with the native enzyme (12) . With the aim of gaining insights into the role of the A-chain in human thrombin, we used in vitro expression analysis of the natural mutant bearing a deletion of Lys 9 (⌬K9). The wild-type (WT) 2 prothrombin and mutant cDNAs were stably transfected in Chinese hamster ovary cell lines expressing high levels of prothrombin for experiments probing their functional properties. In order to understand their different functional properties, we performed a molecular dynamics (MD) simulation of the ⌬K9 thrombin mutant in full explicit water solvent. Our simulation, in conjunction with a comparative analysis of available crystal structures of free or ligand-bound WT thrombins, provided insightful support to the role of the A-chain in affecting conformation and catalytic properties of the B-chain.
EXPERIMENTAL PROCEDURES
Patients-We investigated the molecular defects in two Iranian patients with prothrombin deficiency and a severe hemorrhagic diathesis. Clinical and laboratory findings pertaining to these patients were previously reported in detail (1) .
DNA Analysis-Following DNA extraction from leukocytes, the coding region, intron/exon boundaries, and 5Ј-and 3Ј-untranslated regions of the prothrombin gene were amplified by PCR screened for mutations by single strand conformation polymorphism analysis and sequenced using an ABI PRISM BigDye Terminator Cycle Sequencing Kit (ABI 373; PerkinElmer Life Sciences). The primers used in the PCR and sequencing are identical to those used in a previous study (1) .
Site-directed Mutagenesis and Construction of Expression VectorsFull-length cDNA of human prothrombin (including 38 bp of 5Ј-untranslated region and 97 bp of 3Ј-untranslated region) was obtained by PCR amplification of M13mp18 (kindly provided by Dr. Barbara C. Furie). The construction of plasmid PT7 SalI FII-WT EcoRI was previously described (13) .
To investigate the influence of the Lys 9 deletion (⌬K9) on prothrombin activity, mutant FII-⌬K9 was obtained by site-directed mutagenesis of PT7-SalI FII-WT EcoRI using a commercially available kit (Clontech, Palo Alto, CA). Oligonucleotide (5Ј-CTGTTCGA---GAAGTCGCTGGAG-GACAAAACCGAAAGAGAGCTTCTAGAATCCTACATC-3Ј) spanning nucleotides 1021-1080 of the human FII cDNA were used to introduce an in-frame deletion of 3 bp, nucleotides 1029 -1031 (GAA deletion). This primer also introduced a XbaI restriction site (underlined), arising from two silent CCT to TCT and GGA to AGA mutations at nucleotides 1065 and 1068, respectively, to facilitate screening for clones carrying the mutation. The cloned insert was sequenced, and sequencing confirmed that the mutation had been introduced.
To obtain stable cell lines expressing recombinant FII-WT and FII-⌬K9, we used dihydrofolate reductase-deficient Chinese ovary cells (CHO-DUKX-B11). These cells were grown in ␣-modified essential medium supplemented with 10% fetal bovine serum, 2 mmol/liter L-glutamine, 10 mmol/liter HEPES, pH 7.2, 100 units/ml penicillin G, 100 g/ml streptomycin, and 8 g/ml vitamin K1 (Phytonadione; Abbott), 10 g/ml adenosine, 10 g/ml deoxyadenosine, and 10 g/ml thymidine in a 5% CO 2 atmosphere at 37°C. The DNA of pED-FII-WT or pED-FII-⌬K301 (30 ng) were transfected by electroporation into 5 ϫ 10 6 CHO cells according to the manufacturer's instructions. Two days after transfection, cells were selected for dihydrofolate reductase expression using medium deficient in ribonucleosides and deoxyribonucleotides. A single clone stably transfected with each construct and expressing high levels of FII was selected for further experiments.
Purification of Wild Type and ⌬K9 Prothrombin-Activation of ⌬K9 prothrombin was obtained using the Taipan snake venom, whereas ecarin slowly activated the mutant zymogen (data not shown). It is known that the Taipan snake prothrombin activator acts as a Factor  Xa-Factor Va complex, since it directly activates prothrombin through  cleavages of the Arg   271   -Thr  272 peptide bond at the junction between  A-chain and fragment 2 besides the additional cleavage of the Arg   320   -Ile  321 peptide bond (14) . Prothrombin activation was obtained by incubating for 2 h at 37°C 1 M ⌬K9 prothrombin (or the WT form) with 0.2 mg/ml Taipan snake venom in 50 mM Tris-HCl, 150 mM NaCl, 2 mM CaCl 2 , synthetic phospholipid reagent containing a colloidal silica activator and used at a 1:5 dilution of the stock solution (SynthAsil APTT reagent, Instrumentation Laboratory, Milan, Italy), pH 8.00. The generated active ⌬K9 thrombin was successfully purified by cation exchange HPLC, being eluted ϳ5 min before WT thrombin. This finding is in agreement with the lack of one positive charge related to the missing lysine residue in the A-chain of the mutant thrombin. SDS-PAGE of pooled chromatographic peaks was carried out on 4 -20% gradient gels under both reducing (5% ␤-mercaptoethanol) and nonreducing conditions in a Bio-Rad mini-PROTEAN II apparatus. The pooled peak contained a single band of roughly 36 kDa, whose identity was further checked by N-terminal sequencing. To obtain purified A-chain from both WT and ⌬K9 thrombin, the peak obtained in the ion exchange chromatography was reduced by 5% ␤-mercaptoethanol and analyzed through RP-HPLC using a C4 resin (High Pore RP-304 250 ϫ 4.6 mm; Bio-Rad). The applied gradient was 10 -40% acetonitrile in 0.1% trifluoroacetic acid at a flow rate of 1.0 ml/min. The elution was followed at 224 nm. The peak relative to the A-chain was eluted after 17.8 min for the WT species, whereas it appeared after 17 min in the case of ⌬K9 thrombin. These peaks were pooled, dried, and solubilized in acetonitrile/water/trifluoroacetic acid (49:49:2 by volume) before sequencing was performed. An automatic liquid phase sequencer (ABIPerkinElmer model 477A) connected to an HPLC apparatus (ABIPerkinElmer model 120A, PTH-analyzer), and a Bio-Rad reverse-phase C18 column were used to determine the N-terminal sequencing. Identification of the cleavage products was based on the amino acid sequences of the human prothrombin (15) .
The concentration of recombinant thrombins was measured spectrophotometrically at 280 nm, using an extinction coefficient (0.1%) equal to 1.83. Active site titration was carried out spectrophotometrically, as previously reported (16 (16) , in 10 mM Tris-HCl, 0.15 M NaCl, 0.1% polyethylene glycol 6000, pH 8.00, at 25°C (buffer A). The enzyme concentration was typically 0.5 nM for WT and 5-10 nM for the ⌬K9 thrombin form. In the experiments without sodium, NaCl was substituted with a cation not interacting with thrombin, tetramethylammonium chloride, which was used at the same concentration to keep constant the ionic strength of the solution (17) .
The effect of the viscogenic agent sucrose, used over a 0 -0.8 M concentration range in buffer A, was investigated according to a previously detailed kinetic and analytical scheme (16 -19) . Accordingly, the canonical scheme for serine proteases amidase activity was applied,
where k ϩ1 , k Ϫ1 , k 2 , and k 3 are the kinetic rate constant of the substrate association and dissociation, acylation, and deacylation of thrombin, respectively, and EP* is the acyl-enzyme intermediate, and P is the final product. The equilibrium dissociation constant, K d , can be calculated from the k Ϫ1 /k ϩ1 ratio. Experimental data sets were simultaneously fitted to the appropriate equations (16, 17) , using the GRAFIT software (Erithacus Software Ltd., Staines, UK). Fibrinopeptide A Release-Fibrinopeptide A release by both WT and ⌬K9 thrombin in buffer A was monitored by reverse transcriptase-HPLC, using a previously reported method (20) . Purified plasmin-and fibronectin-free fibrinogen from American Diagnostica (Instrumentation Laboratory, Milan, Italy) was used as substrate. The enzyme concentration was 0.2 and 2 nM, for the WT and the mutated form, respectively. The Michaelis parameters were computed as indicated above for the synthetic substrate.
Measurement of k cat /K m for Protein C Activation and Interaction with
Thrombomodulin-Hydrolysis by WT and ⌬K9 thrombin of zymogen protein C, purchased from American Diagnostica (Instrumentation Laboratory, Milan, Italy), was performed in buffer A, as previously reported in detail (21) . Hydrolysis of protein C (2 M) was followed in the presence of 100 nM human thrombomodulin (American Diagnostica), since in the absence of the cofactor, the reaction was too slow to be correctly analyzed. Likewise, binding of the thrombin forms to immobilized human thrombomodulin (nonlipidated form, from American Diagnostica) was investigated according to a previously reported method (21) .
Inhibition of WT and ⌬K9 Thrombin Forms by Antithrombin, Bovine Pancreatic Trypsin Inhibitor (BPTI), and N-␣-[2-Naphthylsulfonyl-glycyl]-4-amidinophenylalanine-piperidide (␣-NAPAP)-
Pseudo-first order kinetics formalism was used to investigate the interaction of WT and ⌬K9 thrombin forms with antithrombin (AT) (Enzyme Research, Indianapolis, IN) in the absence and presence of heparin in buffer A. In the absence of heparin, AT was used in concentrations ranging between 10 and 15 M in buffer A at 25°C. The reaction with thrombin was started by adding 0.1 nM WT or 5-10 nM ⌬K9, and the release of p-nitroaniline was measured as a function of time at 405 nm. The measurements were performed in duplicate. The association second order rate constant, k on , for thrombin-AT interaction was calculated as reported (22) . Progress curve kinetics was also used to derive the k on value of AT interaction with WT and ⌬K9 mutant thrombin in the presence of high molecular weight heparin from porcine intestinal mucosa (Sigma; sodium salt Grade I-A, 170 United States Pharmacopeia/ mg, average M r ϭ 16,500), as described (22) . Heparin concentration was equal to 75 nM in functional experiments using 0.15 M AT, 0.15 nM WT form, or 10 nM ⌬K9 and 100 M Phe-Pip-Arg-pNA as the substrate.
WT and ⌬K9 mutant thrombin interaction with BPTI (Sigma) was performed in buffer A, according to a previously described "matrix" method (21) . Competitive inhibition of the synthetic substrate Phe-PipArg-pNA hydrolysis was used to monitor the inhibitor interaction with both the WT and ⌬K9 thrombins. BPTI effect on the substrate's hydrolysis was investigated using the inhibitor over a concentration range from 0 to 1 mM, whereas ␣-NAPAP (Sigma) was used between 0 and 100 nM concentration. All of the experimental points taken at different inhibitor concentrations (BPTI or ␣-NAPAP) as a function of the substrate concentration were simultaneously fitted to a competitive inhibition of the Michaelis equation, as previously reported (19) , using the GRAFIT software (Erithacus Software). This method allowed us to calculate the equilibrium dissociation constant of the inhibitor's binding to thrombin.
Measurement of the PAR1 Peptide Hydrolysis-Hydrolysis of the PAR1 peptide (PAR1P, NH 2 -LDPRSFLLRNPNDKYEPFWEDEE-COOH, synthesized by Primm s.r.l., Milan, Italy) by the different thrombin forms was followed by measuring the release of the peptide LDPR, resulting from the cleavage of the NH 2 terminus of PAR1, according to a previously described method (22) . Briefly, 0.5 M PAR1P peptide was incubated with 50 -100 pM WT or 10 nM ⌬K9 thrombins in 10 mM HEPES, 0.15 M NaCl, 0.1% polyethylene glycol 6000, pH 7.5, at 25°C. At time intervals (1, 2, 3, 4, 8, 12 , and 15 min), the reaction was stopped with 0.3 M HClO 4 , and the cleaved peptide was measured by reversed-phase HPLC, using a 250 ϫ 4.6-mm RP-304 column (Bio-Rad), as previously reported (22) .
Interactions with Platelets-We compared the effects of WT and ⌬K9 thrombins on the enzyme capacity to activate gel-filtered platelets, which were prepared in 10 mM Hepes, 0.15 M NaCl, 5.5 mM glucose, 0.2% bovine serum albumin, pH 7.50, at 25°C, according to a previously described method (22) . In these experiments, thrombin concentrations ranged from 0.5 to 128 nM. Aggregation of gel-filtered platelets (3 ϫ 10 5 /l) was studied in a PACKS 4 aggregometer (Helena Laboratories, Milan, Italy), using a final volume of 500 l. Aggregation response was evaluated by taking into account the maximum velocity of transmittance increase per minute (expressed as a percentage of transmittance, set by using plain buffer).
Molecular Dynamics Calculations-The x-ray structure of human thrombin covalently bound to D-Phe-Pro-Arg-methyl ketone, determined at 1.9-Å resolution (Protein Data Bank entry 1ppb) (8) , was used as the starting structure. The covalently bound inhibitor was removed, and the structure of the free enzyme was used as a template for generating the ⌬K9 mutant protein (Swiss-Prot; available on the World Wide Web at www.expasy.ch). The protein structure was solvated with water in a periodic truncated octahedron, to produce a 12-Å water shell. All solvent molecules within 1.5 Å of any protein atom were then removed. The GROMACS 3.1.4-1 software package, running on a Linux PC cluster, was used for the MD simulations and analysis of the trajectories. The total charge of the ⌬K9 protein was ϩ2, and no counterions was added. The entire system consisted of 3060 protein atoms and 12,759 water molecules.
The initial structure ⌬K9 mutant thrombin was energy-minimized by using 200 steps of steepest descent with the protein constrained and then 1000 steps of conjugate gradient, with the entire system free, in order to remove bad contacts. During the simulations, the system was coupled to an external temperature bath with a coupling constants of 0.1 ps (23). The Gromos-96 force field (24) was used for minimization procedures, with a time step of 2 fs. Water molecules were modeled according to the "simple point charge" model (25) . The LINCS algorithm (26) was used to constrain all bond lengths. The nonbonded interactions were cut off at 8 Å (short range cut-off radius) and 12 Å (long range cut-off radius) for both Coulombic and Lennard-Jones interactions. The short range nonbonded interactions were updated every time step, whereas the interactions within the long range radius were updated every five time steps. Initial velocities were assigned according to a Maxwellian distribution at the desired temperature. The density of the system was adjusted by performing the first equilibration runs under number pressure temperature conditions by weak coupling to a bath of constant pressure (p ϭ 1 bar, coupling time of 0.5 ps). The simulation, starting from the initial structure, was equilibrated by 50 ps of MD run with position restraints on the protein to allow the solvent molecules to be relaxed, followed by another 50-ps run without restraints. Production dynamics were performed under number volume temperature conditions for 18 ns, and the coordinates saved every 10 ps.
RESULTS AND DISCUSSION

Expression Study
To investigate the influence of the Lys 9 deletion on prothrombin biosynthesis, transient transfections were performed in COS-7 cells using the dicistronic pED vectors containing either FII-WT or FII-⌬K9 cDNAs. Enzyme immunoassay demonstrated that, compared with FII-WT, the prothrombin antigen level of FII-⌬K9 was 20% in conditioned media (similar to that observed on the patient's plasma) and 14% in cell lysates. Purification of the mutant active thrombin by ion exchange HPLC was effective as demonstrated by SDS-PAGE (see Fig.  1 ), showing a single band with an apparent molecular mass of about 36 kDa (see Fig. 1 ). The identity of the purified ⌬K9 protein was checked by N-terminal sequencing of the A-chain, which showed the presence in both the mutant and the WT enzyme of the TFGSGE sequence, which corresponds to the segment generated upon cleavage of the prothrombin Arg 284 -Thr 285 peptide bond. This N-terminal sequence is autocatalytically produced by meizothrombin, which releases a N-terminal 13-mer peptide from the A-chain (27, 28) . It is noteworthy that a long incubation time was indeed necessary to obtain a full ⌬K9 prothrombin activation by Taipan snake venom, at variance with WT-FII, which under the same experimental conditions was almost fully activated after a 20-min incubation with Taipan venom (data not shown).
Hydrolysis of the Synthetic Substrate Phe-Pip-Arg-pNA:
Effects of Na ϩ and Viscosity
The effect on thrombin functions by Na ϩ binding to the 225-loop, which triggers the transition of the enzyme from a slow form to a more active (fast) form, has been well established (29) . Under the experimental conditions of this study, the best fit k cat and K m values for the WT form were equal to 88.9 Ϯ 1.5 s Ϫ1 and 1.90 Ϯ 0.13 M in the Na ϩ -bound (fast) form, compared with 35.8 Ϯ 1.2 s Ϫ1 and 9.98 Ϯ 0.84 M in the Na ϩ -free (slow) form. The same kinetic parameters in the ⌬K9 thrombin were equal to 4.1 Ϯ 0.2 s Ϫ1 and 1.6 Ϯ 0.2 M in the fast form, compared with 3.0 Ϯ 0.3 s Ϫ1 and 5.1 Ϯ 0.14 M in the slow form. If the ratio between the k cat /K m values between the fast and the slow form is defined as r, then an energetic contribution (⌬G c , kcal/mol) associated to such a functional transition can be calculated. Accordingly, ⌬G c ϭ RT ln r, where R is the gas constant and T is the absolute temperature. The difference between the ⌬G c pertaining to the WT and the mutant form (i.e. ⌬⌬G c ϭ WT ⌬G c Ϫ m ⌬G c ) expresses the energetic contribution of the deleted lysine residue to the stabilization of the fast form. Based on our experimental data, a ⌬⌬G c of Ϫ0.65 kcal/mol was calculated, which significantly provided evidence that the allosteric coupling between Na ϩ binding and the stabilization of the enzyme in its more active form is reduced by the lysine deletion. This would suggest that Lys 9 deletion in the light chain should confer a "slow-like" conformation to the thrombin mutant. As further evidence of this behavior, using tosyl-Gly-Pro-Arg-pNA (Sigma) as substrate and thrombin in the fast forms, at 25°C and pH 8.00, K m values were equal to 3.62 Ϯ 0.40 M and 5.50 Ϯ 0.60 M for ⌬K9 and WT thrombins, respectively, whereas k cat values were 9.34 Ϯ 1.50 and 101 Ϯ 2.50 s Ϫ1 for ⌬K9 and WT thrombins, respectively. The above data suggest that possible conformational variations induced in the active site by the deletion of Lys 9 may affect the intermediate steps of catalysis rather than substrate binding, which was proved to be even slightly favored in the mutant compared with the WT enzyme.
The viscosity perturbation experiments showed that the ⌬K9 mutant has a slightly better interaction with the synthetic substrate D-Phe-Pip-Arg-pNA, by virtue of both a moderate increase of the association rate constant and decrease of the dissociation rate value (Table I) . These experiments also showed that the hydrolytic cycle undergoes a strong decrease of the acylation step and that that Phe-Pip-Arg-pNA does not act as a "sticky" substrate for the mutant thrombin, at variance with what was observed for the WT form. As a matter of fact, the k 2 /k Ϫ1 ratio was equal to about 0.02 and 0.5 for ⌬K9 and WT forms, respectively (Table I) .
Fibrinopeptide A Release
The hydrolysis of the A␣-chain from fibrinogen is markedly reduced in the ⌬K9 mutant thrombin (Fig. 2) . This effect is mostly due to a drastic change of the k cat value, which decreases from 45.3 Ϯ 2 s Ϫ1 in the WT to 1.82 Ϯ 0.1 s Ϫ1 in the mutant form. The K m parameter also changed, its value being equal to 5.1 Ϯ 0.6 M in the WT and 13 Ϯ 2 M in the ⌬K9 mutant form (Table II) .
Protein C Activation and Interaction with Thrombomodulin
Hydrolysis of zymogen protein C by the ⌬K9 thrombin form in the absence of thrombomodulin could not be followed under the experimental conditions used in this study, since the rate of protein C cleavage was too severely impaired to be monitored. In the presence of 100 nM thrombomodulin, the k cat /K m value was about 30-fold lower in the mutant thrombin (Table II) , such an effect not depending upon an impairment of thrombomodulin interaction, as solid phase binding experiments proved. The K d values of thrombomodulin binding were indeed very close in the two thrombin forms (Table II) .
Interaction with PAR1 and GpIb␣ and Activation of Gel-filtered Platelets
The ⌬K9 thrombin was defective in activating gel-filtered platelets, the EC 50 value being equal to 38.6 Ϯ 6 nM in the mutant and 2.1 Ϯ 0.3 in WT form. In order to investigate the main causes of this impaired function, we studied the in vitro hydrolysis of the PAR1 38 -60 peptide. This peptide bears both the sequence with the thrombin cleavage site and the domain interacting with the fibrinogen recognition exosite of the enzyme. In solution, this substrate showed a severe defect in interacting with ⌬K9, largely due to a decrease of the k cat value, as reported in Table II Ϫ1 s Ϫ1 in the mutant form, which corresponds at 25°C to a net decrease of 2.8 kcal/mol in the activation free energy calculated on the basis of the ratio between the k cat and K m values.
The interaction with immobilized GpIb␣ was substantially unaffected by the mutation, the K d values being similar in the two forms (Table II) . Thus, the defective platelet activating capacity of the mutant thrombin was mostly attributed to an impaired PAR1 interaction.
Interaction with Physiological and Synthetic Inhibitors
The best fit second order rate constants for both WT and ⌬K9 thrombin interaction with AT in the presence and absence of heparin are listed in Table III . Under both conditions, AT interaction with the mutant thrombin decreased about 20 times, compared with the WT form. Such a defective interaction, not depending upon the heparin effect, suggests an impairment of the processes leading to the formation of the stable thrombin-AT complex.
Inhibition experiments under steady state conditions showed that the interaction of the ⌬K9 thrombin with ␣-NAPAP was facilitated, the measured K i value being equal to 0.66 Ϯ 0.03 nM versus 2.1 Ϯ 0.2 nM of the WT form (Table III) . Likewise, BPTI binding was facilitated in the ⌬K9 form, the measured K d value decreasing about 3 times compared with the K d value determined with the WT form.
All of the above functional studies showed that the catalytic machinery of thrombin is negatively affected by the loss of Lys 9 in the A-chain, suggesting that conformational changes occurring in the light chain may propagate to the active site cleft of the enzyme. This was a partly unexpected result, due to some contrasting findings reported in the literature about the influence of the A-chain on the catalytic activity of the human thrombin (11, 12) . In fact, some authors provided evidence of a positive effect of the A-chain on the catalytic function of the human thrombin (12), whereas another group showed that the elimination of the A-chain in the bovine thrombin caused a nil effect (11) .
Molecular Modeling of the Mutant Thrombin
Global Properties-In this study, we performed an MD simulation of a virtually generated ⌬K9 mutant three-dimensional model and compared its key geometrical and conformational properties with available crystal structure data of WT enzyme forms. The goal was to detect structural properties possibly related to the observed different functional properties. As the starting model we used the x-ray structure of human thrombin covalently bound to D-Phe-Pro-Arg-methyl ketone determined at 1.9-Å resolution (Protein Data Bank entry 1PPB) (8) . The inhibitor was removed, and the structure of the free enzyme was used to generate the mutant protein (Swiss-Prot; available on the World Wide Web at www.expasy.ch). The ⌬K9 thrombin model was then allowed to evolve in fully explicit water solvent, using the MD protocol described in detail under "Experimental Procedures." Recently reported MD simulations performed by De Filippis et al. (31) with WT thrombin, using a protocol similar to that adopted by us, had shown that after about 5 ns, the protein undergoes a conformational transition from a more open conformation, proposed to be related to the fast form, to a more compact conformation, proposed to be related to the slow form. Decrease of the protein surface exposed to water and reduction of the radius of gyration (R g , defined as the massweighted root mean square distance of a collection of atoms from their common center of mass) after 5-ns simulation had been brought as proofs of a more compact structure of the slow form with respect to the more active (fast) form. This model is in good agreement with the recent x-ray crystallographic studies by Huntington and Esmon (32), revealing a more "open" overall conformation of the fast form compared with the slow Table II. form of thrombin. Our MD computational approach, preliminarily applied to the study of the WT thrombin, reproduced a behavior quite similar to that reported in literature (31) . Interestingly, the same MD simulation protocol applied to the ⌬K9 mutant showed both similar and dissimilar behaviors. The mutant protein structure equilibrates with the potential energy of the system after about 5 ns. The root mean square deviation from the starting structure reaches a plateau value of 0.40 Ϯ 0.05 nm between 5 and 18 ns. The overall secondary structure elements are in general stable along the whole trajectory (less than 1% of the secondary structures, mainly ␣-helices, were lost or varied during the production dynamics). The analysis of root mean square deviation fluctuation during the simulation for each atom position in the backbone (Fig. 3A) , with respect to the starting structure, revealed the residues in the A-chain, the as those having the highest degree of flexibility (root mean square deviation Ͼ0.3 nm). Conformational motions involving residues within the S3 site (especially Trp 215 and Ile 174 ) were also inferred from the plot in Fig. 3A . These conformational changes were exactly observed when MD simulation was performed on the virtual mutant with deletion of the Lys 10 instead of Lys 9 residues (data not shown), indicating that deleting Lys 9 or Lys 10 should result in proteins having similar MD behaviors. From the point of view of the global properties, the plot displaying the variation of R g as a function of time (Fig. 3B ) was of particular diagnostic significance, indicating that the transition around 5 ns involves a smaller diminution of R g (it ranges from an average value of 1.80 nm in the first 5-ns simulation to an average value of 1.78 nm in the last 13-ns simulation), compared with the WT form (R g values range between 1.84 and 1.76 nm, respectively). A more compact conformation of the ⌬K9 mutant protein along all of the simulation time, inferred from the plot in Fig. 3B , is consistent with our experimental data. In fact, Na ϩ was responsible for a 4.5-fold and a 13-fold increase of the k cat /K m value of Phe-Pip-Arg-pNA hydrolysis by the ⌬K9 mutant and WT thrombin, respectively.
A-chain Conformation-Deleting Lys 9 resulted in a restructuring of the light chain, with an average increase of the contact surface area of 85 Å 2 (Fig. 4) . This finding, which gains relevance by taking into account the deletion of one residue in the mutant light chain, should mainly depend upon the lack of contacts (ion pairs reinforced by hydrogen bonds), which instead stabilizes the light chain in the WT protein in a conformation having a smaller contact surface. An account of the relevant contacts within the A-chain and between the A-and B-chains was provided by monitoring the ionic interactions during the last 10-ns simulation of the ⌬K9 mutant. These ionic bonds had been proved important in stabilizing the Achain in WT thrombin in a boomerang-like conformation (8) . The results reported in Table IV showed that only the distances of the contacts Lys 14a -Asp 14 , Glu 13 -Arg 14d (intrachain salt bridges) and Asp 1a -Arg 206 , Glu 14e -Lys 186d (interchain salt bridges) were close to those reported to be optimal in the crystal structure (8) , whereas the remaining ionic interactions appeared disfavored. Such a change in electrostatic contacts could be a major cause of the refolding of the A-chain in the ⌬K9 mutant.
Changes in the Specificity Sites and Surface Loops-In order to detect whether and how much the deletion of Lys 9 and the subsequent change in folding of A-chain affected conformational change in molecular regions mainly responsible for functional properties, we investigated in detail the MD behavior of residues located in the specificity sites (S1, S2, and S3) and in insertion loops (Table V) . According to x-ray structure data (8) and similar MD studies (31), our MD simulation showed that the Trp 148 loop appears as a region of high mobility, whereas the conformation of the Na ϩ -binding site remained quite stable during the simulation (31) .
Conformational changes of ⌬K9 residues within the S2 pocket (Trp 60d loop) are highlighted in the root mean square deviation calculations for backbone atoms (Fig. 3A) . Also, residues lining the S3 site, such as in particular Trp 215 and Ile 174 , are located in protein loops highly fluctuating during the production dynamics. An account of the geometrical and conformational transitions involving residues within the specificity sites (namely Asp 189 in the S1 site, Trp 60d and Tyr 60a in the S2 site, and Trp 215 in the S3 site) that could significantly affect substrate or inhibitor docking into the enzyme cleft was obtained by monitoring the relative position of their side chains during the simulation of the ⌬K9 mutant form. Thus, measuring Asp 189 -Trp 60d relative positions resulted in an average distance between the centers of masses of 22.4 Ϯ 1.4 Å in ⌬K9, which is longer than that measured in the x-ray structure WT thrombin (19.7 Ϯ 0.6 Å). The difference in the relative position of the aromatic side chains within the S2 site was even more appreciable, the distance between Trp 60d and Tyr 60a being about 2 times longer in the mutant (8.2 Ϯ 0.6 Å), during the last 10-ns simulation, than in the WT forms (4.8 Ϯ 0.1 Å). We reputed this result of particular relevance, since such a longer distance was observed both in the first part (6.4 Ϯ 1.2 Å during the first 5 ns) of the simulation, believed to be related to the fast form, and the second part (7.7 Ϯ 1.2 Å during the last 13 ns) of the simulation, probably related to the slow form (31) . This could mean that the opening of the S2 site should similarly affect binding and catalysis both in the fast and in the slow allosteric forms. Such a geometrical variation in the S2 site may be in agreement with the increased association rate constant of the synthetic substrates and the moderate but significant decrease of K i value of the inhibitor ␣-NAPAP, possibly due to a better accommodation of the P2 moieties in the ligands into the corresponding S2 enzyme binding site (Tables I and III ). The models of the complexes between the two thrombins and NAPAP (not shown) revealed that the most striking difference between x-ray WT thrombin structures and ⌬K9 mutant model pertains 1) to the S2 site, which rests as a lid on the active site of WT but not the mutant and 2) to Trp 215 belonging to the S3 site, which is strongly shifted apart. It is noteworthy that the MD simulation revealing the expulsion/ rearrangement of the S2 pocket and the global enlargement of the so-called "aryl binding site" in the mutated enzyme is consistent with the experimental finding that BPTI affinity increased roughly 3 times in the ⌬K9 form (Table III) . Although this is not a dramatic effect, previous studies showed that the Trp 60d loop is a major element opposing to the formation of thrombin-BPTI interaction, whereas its expulsion/rearrangement is able to increase the inhibitor's affinity for the enzyme (33) . This arrangement should enhance the "capture radius" of the catalytic site, based on Hill's terminology (34) , optimizing the complementarity of the inhibitor (or substrate) with the enzyme in the resting state. However, the steady-state measurements of this study indicated that the conformational transitions caused by the mutation/deletion reduce the complementarity of the substrate's binding to the enzyme's transition state, reducing the k cat /K m value. This effect is largely due to a drastic decrease of the acylation rate (Table I) . However, although acylation remains the rate-limiting step of the catalytic cycle, both the acylation and deacylation reactions are similarly affected by the mutation (Table I , present only in the first few ns of the simulation, are loss in the last 10-ns simulation, when the ⌬K9 undergoes a conformational transition triggered by the restructuring of the A-chain folding. A careful look at the enzyme clefts shows a clear geometrical distortion of the active site in the model of ⌬K9 mutant generated in this study compared with the crystal structure of a WT form taken as reference (Fig. 5) . In the three-dimensional structure of WT thrombin, the side chain centroids of the amino acids Asp 189 (S1), Trp 60d (S2), and Trp 215 (S3) and the amino acids of the catalytic triad seem to lie on nearly parallel planes, whereas in the lowest energy model of the ⌬K9 mutant, the two planes are quasiorthogonal. The distortion of the relative positions of the above amino acids into the catalytic pocket of the ⌬K9 mutant may be hypothesized to be a major cause for the drastic decrease of the specificity constants measured with both synthetic and physiological substrates. Taken together, our results provided a computational support to the observation that Lys 9 deletion could affect, through long range allosteric effects, the active site conformation. The latter should fit well established geometrical constraints (bond lengths and angles) in order to increase the nucleophilicity of the Ser 195 -O ␥ and a given relative geometry involving Ser 195 -O ␥ and amide carbonyl C of the substrates. An optimal distance between the Ser 195 -O ␥ and the carbonyl C and the pyramidalization at the carbonyl C allow the tetrahedral intermediate to be efficiently formed, according to the Bü rgiDunitz-Shefter relation for nucleophile-electrophile interaction (35, 36) .
Conclusions
A detailed understanding of the intramolecular mechanisms responsible for the functional defects observed in the ⌬K9 mutant deserves further experimental and computational studies. Nevertheless, the results obtained from MD simulation reported herein allowed us to identify conformational changes that, starting from a restructuring of the A-chain folding, are transmitted to key molecular regions within the catalytic pocket, through a "domino-like" effect. It must be pointed out that, when present in other serine proteases, such as tissue plasminogen activator or urokinase, a noncatalytic A-chain disulfide-bonded to the active B-chain seems to play allosteric roles for the involved enzyme (37) . On the basis of the present findings, a similar conclusion can be hypothesized for the thrombin A-chain as well.
Our MD analysis highlighted the modification within the "aryl binding site," especially the expulsion/rearrangement of the Trp 60d side chain (S2 site) and the shifting of Trp 215 (S3) and geometrical distortion within the catalytic triad as the possible main determinants of the decrease of ⌬K9 catalytic activity.
Very recently, it has been shown that in serine proteases, evolutionarily conserved sparse networks of amino acid interactions represent the structural machinery by which the allosteric communication can take place, so that chemical signals originating at one site in an enzyme molecule may reliably propagate to distant functional sites (38) . Two main networks of linked groups were identified, although the detailed mechanisms generating allosteric coupling are still unclear (38) . Our results seem in agreement with those findings, indicating that critical A-chain residues could also participate to the allosteric linkage with the network around the S1 catalytic site, involving some surface loops, such as the 60-loop (38) .
Finally, the evidence that the structural and conformational state of the A-chain can affect the catalytic activity of thrombin may have implications in the field of antithrombotic agent pharmacology. The recent development of peptides that bind to surface loops of coagulation factor VIIa, selectively inhibiting the enzyme activity (39), shows how stabilization of the "inactive" forms of this serine protease by exosite ligands can strongly affect enzyme function. Further studies are needed to show whether this could be a valuable approach for the modulation of thrombin activity.
